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ABSTRACT 
Background: With a series of outbreaks spanning the globe, the Zika virus has transitioned, in a short 
time, from an obscure virus to a public health emergency. Locally transmitted Zika has reached the United 
States, leading to increased concern regarding further transmission and the potential impact on public 
health. 
 
Methods: The present study was conducted to examine the propagation and effects of Zika in the United 
States by reviewing published literature regarding Zika in conjunction with updates from the Centers for 
Disease Control and Prevention. To gauge the regional response, including prevention and control efforts, 
interviews were conducted with public health and mosquito control officials. 
 
Results: Exposure to Zika may be through vectors, sexual activity with an infected partner, or congenitally 
to the unborn fetus. Regardless of the mode of transmission, Zika infection may result in serious 
neurological consequences in adults and especially in fetuses.  
 
Conclusions: Prevention of Zika infection is key to successful control of the virus. Vector control and 
surveillance as well as personal protection from virus exposure are necessary to avoid the potentially 
devastating effects of the virus. In an effort to prevent further spread, public health authorities are 
implementing strategies for public education, prevention, and containment. 
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In a short time, the Zika virus has moved from a 
relatively obscure virus to a cause of 
international concern. Zika virus was first 
isolated in 1947 in the Zika Forest of Uganda 
during a yellow fever surveillance project (Dick, 
1952). Since its discovery, Zika has remained 
relatively benign, causing only sporadic, isolated 
cases. In 2007, this changed as Zika re-emerged, 
causing epidemic outbreaks in various islands of 
the Pacific (Duffy et al., 2009; Ioos et al., 2014). 
In the Americas, February 2015 marked the 
beginning of a Zika pandemic that has sparked 
international alarm. The outbreak began in Brazil 
and quickly spread throughout South America 
and the Caribbean. A high incidence of 
neurological effects among Zika-infected adults 
and fetuses led to a call for action to combat 
further spread of the virus. Across the United 
States (US), hundreds of travel-related and 
multiple sexually transmitted cases have been 
reported (ECDPC, 2015; CDC: Case counts in 
the US, 2016). In July 2016, cases identified in 
Florida marked the first local transmission of 
Zika in the continental US (CDC: Case Counts in 
the US, 2016; CDC: FL investigation, 2016). 
Relative to these outbreaks, this review examines 
the propagation and potential effects of the Zika 
virus in the US, including responses by front-line 
public health authorities to prevent transmission 
of the virus and to initiate protocols for 




This review was conducted by assessing 
published literature regarding the Zika virus as 
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well as current and updated guidance from the 
Centers for Disease Control and Prevention 
(CDC) via its website. In addition, unstructured 
interviews were conducted with the administrator 
and lead epidemiologist at the Georgia 
Department of Public Health, Coastal District, to 
investigate regional response protocols and 
prevention efforts. Further, the director and the 
lead entomologist of Chatham County Mosquito 
Control were interviewed and were joined in the 
field to examine vector control and surveillance 





Although the Zika virus can be transmitted in 
various ways, the primary route is via mosquito 
vectors. During this vector transmission of Zika, 
the virus in the saliva of an infected female 
mosquito is transferred into the skin of a human 
during a blood meal. The virus is deposited in 
the epidermis and dermis of the host, infecting 
several cell types that provide a haven for viral 
replication and allow dissemination throughout 
the body (Hamel et al., 2015). Although Zika 
may be transmitted by several mosquito species, 
in the Americas, Aedes aegypti, commonly 
known as the yellow fever mosquito, appears to 
serve as the main vector (Tilak et al., 2016). A. 
aegypti is primarily an urban mosquito, meaning 
that it prefers a habitat in close contact with 
humans. The mosquito typically dwells around 
or in homes, increasing the chances of viral 
transmission. Females deposit their eggs in 
small, stagnant bodies of water, preferring 
household containers. Since adult A. aegypti 
mosquitoes are relatively poor fliers, they tend to 
dwell relatively close to their hatch site if a food 
source is available, making them a persistent 
nuisance once established around a home. In 
recent years, the distribution of A. aegypti in the 
US has declined, mainly due to the arrival of the 
more competitive A. albopictus species. 
Although some populations are still present in 
the southern US, great numbers of A. aegypti are 
primarily found only in Florida and regions 
along the Gulf Coast (Zettel & Kaufman, 2013; 
CDC: Dengue entomology and ecology, 2016; 
Heusel & Moulis, communication). Despite the 
wider distribution of A. albopictus, this species is 
a less efficient vector of Zika and less likely to 
cause a major outbreak (Chouin-Carneiro et al., 
2016; Hotez, 2016).  
 
In addition to vector transmission, Zika can be 
transmitted by other means, leading to increased 
concern regarding control of the virus. Sexually 
transmitted cases have been reported across the 
US (CDC: Case counts in the US, 2016). Zika 
viral RNA has been detected in semen up to 93 
days after the patient’s symptomatic period of 
illness, indicating possible transmission to a 
sexual partner months after infection (Musso, 
Roche, Robin et al., 2015; Atkinson et al., 2016; 
Brooks et al., 2016; Mansuy et al., 2016). A case 
of probable sexual transmission from an infected 
female to her male sexual partner has also been 
reported (Davidson et al., 2016; Moreira et al., 
2016). In Brazil, there has been probable 
transmission of Zika by transfusion of blood 
products from an infected donor (Barjas-Castro 
et al., 2016). The possibility of transmission of 
Zika by transfusion has been suspected, as other 
related viruses have been transmitted in this 
manner (Lanteri et al., 2016; Musso, Stamer 
et al., 2016).  
 
Although up to ninety percent of individuals 
infected with Zika will be asymptomatic, those 
developing symptoms generally suffer mild flu-
like symptoms of short duration that may be 
accompanied by a maculopapular rash (Duffy 
et al., 2009; Ioos et al., 2014; CDC: Zika virus 
symptoms, 2016; Musso & Gubler, 2016). In 
addition, Zika-infected individuals may be at a 
greater risk for development of Guillain-Barré 
syndrome (GBS). After the epidemics in the 
Pacific and Brazil, an unusually high incidence 
of new cases of GBS was reported for Zika-
infected individuals (Arujo et al., 2016; Musso & 
Gubler, 2016; Silva & Souza, 2016). GBS is an 
acute-onset, autoimmune-mediated peripheral 
polyneuropathy that can result subsequent to a 
variety of infections or as a result of idiopathic 
causes. The exact mechanism of GBS in the 
context of Zika infection is unclear, but it has 
been hypothesized that, during viral replication, 
the virus may incorporate host gangliosides into 
its makeup, eliciting an immune response that 
cross-reacts with normal gangliosides of the host 
causing self-reactivity against the peripheral 
nervous system. The resulting demyelination 
causes disruption in neural signaling and 
potential axonal degradation (Anaya et al., 2016; 
Cao-Lormeau et al., 2016). In severe cases, 
muscle weakness and dysfunction, which are 
commonly experienced, may compromise 
breathing (Cao-Lormeau et al., 2016, Musso & 
Gubler, 2016). 
 
Vertical transmission of Zika from an infected 
mother to her fetus during pregnancy has been 
linked to congenital fetal Zika infections. Recent 
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evidence, derived with animal models, has 
suggested that the virus is transmitted to the fetus 
across the placenta. Although the exact 
mechanism by which the virus crosses the 
placental membrane is uncertain, it has been 
hypothesized that the virus crosses from the 
maternal bloodstream in the chorionic villi to the 
placenta, where it is amplified before spreading 
into the fetal circulation and moving to infect 
neural progenitor cells (NPCs) (Miner et al., 
2016; Quicke et al., 2016; Silva & Souza, 2016; 
Wu et al., 2016).  
 
Congenital Zika infection of the developing fetus 
may result in serious neurological defects, 
including microcephaly, along with other 
developmental anomalies primarily affecting the 
central nervous system (Driggers et al., 2016; 
Hazin et al., 2016; Kleber et al., 2016; Mlakar et 
al., 2016; Musso & Gubler, 2016; Silva & Souza, 
2016). In the US, as of July 2016, there have 
been at least twelve newborns with congenital 
birth defects due to Zika, with more cases likely 
to follow (CDC: Outcomes of pregnancies, 
2016). It is thought that the Zika virus is 
associated more with a disruption in neural 
development, rather than neural destruction 
(Hazin et al., 2016). Cortical NPCs, which would 
normally develop into the cerebral cortex, are a 
key target for the virus. Infection of these cell 
populations with Zika results in dysregulation of 
the cell cycle and in attenuation of neural 
development (Cugola et al., 2016; Li et al., 2016; 
Tang et al., 2016). In Zika-infected fetuses, 
ocular abnormalities, intrauterine growth 
restriction, and fetal demise have also been 
reported (Brasil et al., 2016; de Miranda et al., 
2016; de Paula Freitas et al., 2016; Mlakar et al., 





With the potential of a major Zika outbreak in 
the continental US, many state and local 
agencies have stepped up efforts to prevent 
spread of the virus. As the primary route of 
transmission is via mosquito vectors, many of 
these efforts are centered on mosquito control. 
Effective control, however, is often challenging. 
In most areas of the US, mosquito control is 
dealt with on a local level with funding and 
organization provided by local governments. 
This can cause discontinuities across a region or 
state, as many areas lack professional mosquito 
control entities or may be poorly funded.  
 
Effective and efficient mosquito control is 
dependent upon mosquito surveillance programs, 
which allow for identification of the specific 
mosquito species and their population numbers 
in a particular area. This information can ensure 
that mosquitoes, especially those that may serve 
as disease vectors, can be targeted by control 
efforts. Information collected from surveillance 
may affect the type and amount of pesticide 
applied, the method and time of application, and 
area in which it is applied. In areas that lack a 
professional mosquito agency, mosquito 
surveillance is often nonexistent (Heusel & 
Moulis, communication).  
 
In preparation for the Zika threat, some states 
have taken a proactive approach to address the 
lack of surveillance. The Georgia Department of 
Public Health (GDPH), for example, has hired 
new environmental health employees to conduct 
surveillance in areas of the state where it is 
lacking. This surveillance primarily follows A. 
albopictus and A. aegypti, the two known vectors 
of Zika in the US (Heusel & Moulis, 
communication; McCall & Thornton, 
communication). Surveillance is conducted using 
specially designed traps, such as the widely used 
Biogents Sentinel® trap, that target both of these 
Aedes species (Cornel et al., 2016; Heusel & 
Moulis, communication). Once identified, the 
species may be targeted by a combination of 
adulticides and larvicides. Since both A. 
albopictus and A. aegypti usually dwell in close 
vicinity to homes and breed in household 
containers, pesticide applications that target 
these areas is essential for effective control (Rios 
& Maruniak, 2011; Zettel & Kaufman, 2013; 
CDC: Surveillance and control, 2016; Heusel & 
Moulis, communication). In many areas, aerial 
application may be beneficial, as this approach is 
not limited by roadway access. This method, 
however, may not be effective in treating 
container-breeding sites in congested urban areas 
(Heusel & Moulis, communication). 
 
Controlling the vectors of Zika depends heavily 
upon public involvement to help eliminate 
mosquito-breeding sites around homes. In 
response, public health officials urge the public 
to become involved in the control effort. To 
spread awareness, the GDPH has instituted a 
public education campaign known as “Tip and 
Toss.” The campaign urges citizens to be 
involved in reducing mosquito-breeding sources 
around their homes by emptying or eliminating 
water-holding containers (GDPH: Tip ‘n toss, 
2016; Rey & Connelly, 2016; McCall & 
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Thornton, communication). Involvement of 
entire communities is essential for the success of 
such programs. Unfortunately, in some cases, 
there may be residents who are reluctant or 
refuse to participate. This allows mosquito-
breeding sources to remain on properties and 
may undermine the community effort (Petersen 
et al., 2016; Heusel & Moulis, communication). 
In addition to eliminating breeding sites, 
authorities are striving to increase public 
awareness concerning ways to prevent mosquito 
bites through public outreach campaigns and 
strategically placed informational signage, such 
as in airports. To prevent mosquito bites, 
officials advise wearing, while outdoors, 
lightweight clothing that covers exposed areas of 
skin and recommend, if outdoors for long 
periods, treating clothing with permethrin to 
deter mosquitoes (DeRaedt et al., 2015; CDC: 
Zika virus prevent mosquito bites, 2016; GDPH: 
Zika virus awareness campaign, 2016; McCall & 
Thornton, communication). Perhaps the most 
effective way to prevent mosquito bites is to 
apply an effective insect repellant before going 
outdoors. The most recommended personal 
repellants are those containing DEET (20-30%), 
although others containing picardin, Bayrepel, 
icardin, and IR3535 are also approved by the 
Environmental Protection Agency and CDC 
(CDC: Zika virus prevent mosquito bites, 2016; 
GDPH: Zika virus awareness campaign, 2016). 
For those seeking a natural alternative to 
synthetics, repellants containing oil of lemon 
eucalyptus are effective (CDC: Zika virus 
prevent mosquito bites, 2016). 
 
In addition to preventing mosquito bites, care 
should be taken to prevent sexual transmission of 
Zika. All sexual couples in which one or both 
partners live in areas of ongoing local 
transmission or have traveled to these areas 
should take precautions before engaging in any 
form of sexual activity. This is especially 
important for pregnant women and women who 
are planning to become pregnant. Due to the 
longevity of Zika particles in semen and their 
unknown duration in vaginal fluids, the CDC 
currently recommends that, for at least six 
months after the symptomatic infection (or 
suspected infection) of a partner, couples utilize 
barriers before any type of intercourse. For 
couples in which neither has experienced 
symptoms, barriers are suggested for at least 
eight weeks after travel to an area of local 
transmission. Couples living in an area of 
ongoing transmission should use barriers as long 
as there is Zika reported in their area. Pregnant 
women with a partner who has traveled to or 
lives in a Zika area should utilize barriers 
throughout the duration of pregnancy or abstain 
from sexual activity to prevent potential 
infection of the mother and fetus (Brooks et al., 
2016; CDC: Zika virus protect yourself during 
sex, 2016). 
 
The discovery, in Brazil, of probable Zika virus 
transmission by blood transfusions has prompted 
a federal effort to protect the US blood supply. 
To prevent the distribution of infected blood 
products, the Food and Drug Administration 
(FDA) has issued guidelines for blood collection 
centers, including immediate testing of all 
donated blood products collected in the US 
(FDA: FDA advises testing, 2016). Testing may 
be conducted on individual blood donations by 
use of a newly developed nucleic acid test. 
Donated plasma and apheresis platelets may be 
treated with pathogen reduction technology 
(Kuehnert et al., 2016). 
 
Containment 
While prevention of Zika infection is the goal, 
rapid identification and containment after an 
infection occurs is essential to prevent an 
isolated outbreak from developing into an 
epidemic. With the arrival of Zika to the 
continental US, federal, state, and local 
authorities have prepared containment plans in 
the event that an outbreak does occur. The first, 
and perhaps the most important, step after an 
infection is an accurate and timely diagnosis, 
which is largely dependent on healthcare 
providers. Upon examining a patient with 
suspected Zika infection, providers are directed 
to notify the Department of Public Health 
immediately (CDC: Interim CDC Zika response 
plan, 2016; McCall & Thornton, 
communication). Despite the fact that molecular 
and serological testing has been made available 
to state public health laboratories, accurate 
diagnosis of Zika infection is difficult. Testing 
may not yield a correct result depending on the 
time of sampling and the high degree of cross 
reactivity between related viruses. In many 
cases, a series of tests requiring considerable 
time, especially for laboratories with large test 
loads, must be conducted to reach a definitive 
result of infection status (CDC: Revised 
diagnostic testing, 2016; Musso & Gubler, 2016; 
Plourde & Bloch, 2016; McCall & Thornton, 
communication).  
 
In the state of Georgia, once a suspected case is 
reported, the GDPH contacts the patient as soon 
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as possible, even if results of Zika testing are still 
pending. The GDPH advises patients on methods 
to prevent further local transmission, including 
avoidance of unprotected sexual contact and 
prevention of mosquito bites, which could spread 
the virus to others. The GDPH (or local 
mosquito control entities) may also conduct a 
home visit and mosquito surveillance around the 
index case site. If the area is conducive to 
mosquito breeding, public authorities may 
intervene to reduce the risk of transmission from 
the index case (CDC: Interim CDC Zika 
response plan, 2016; Ndeffo-Mbah et al., 2016; 
Heusel & Moulis, communication; McCall & 
Thornton, communication). The GDPH also 
distributes educational materials throughout the 
surrounding area, warning the residents of 
possible Zika transmission and outlining steps to 
protect themselves (GDPH: Zika virus awareness 
campaign, 2016; McCall & Thornton, 
communication). The CDC, also notified in the 
case of potential local transmission, offers 
support to local authorities. If needed, the CDC 
activates emergency response teams to aid in 
surveillance, vector control, communications, 
and technical support at the scene (CDC: Interim 
CDC Zika response plan, 2016). 
 
Future outlook 
No specific treatment or vaccine for Zika 
infection currently exists, but researchers are 
working to develop these life-saving 
interventions. Investigators and public health 
authorities are hopeful that a Zika vaccine is 
attainable, as vaccines have been developed for 
other flaviviruses (Dowd et al., 2016). Several 
experimental vaccines have already entered 
phase I clinical trials or are scheduled to begin 
soon, including bacterial DNA-based vaccines 
and a more traditional vaccine containing 
inactivated virus (Inovio, 2016; NIH, 2016; 
Pellerin, 2016). A recent study with murine 
models has found both DNA-based and 
inactivated viral vaccines to be effective and 
shows promise for use in humans (Larocca et al., 
2016).  
 
Despite rapid development and advancement to 
clinical trials, an approved vaccine for Zika 
could still be years away. Investigational 
vaccines must be vetted for safety and 
effectiveness through rigorous clinical testing 
before being considered for FDA approval. The 
complex approval process may take up to two 
years. Vaccine applications granted priority 
status, such as Zika is likely to receive, may 
undergo expedited review but can still take 
several months to receive approval (Marshall & 
Baylor, 2011; Pickering & Walton, 2013; Singh 




The Zika virus has recently emerged onto the 
world stage, causing epidemic outbreaks 
circumventing the globe. With the arrival of Zika 
transmission to the US, public health authorities 
and healthcare providers are preparing for new 
outbreaks. Controlling mosquito vectors and 
protecting people from exposure through 
possible routes of transmission are key to 
successful prevention. These efforts are of 
paramount importance to prevent possible 
infection of adults and developing fetuses. With 
an effective vaccine possibly years away and no 
specific treatment for Zika infection, prevention 
and containment must be initiated immediately 
to avoid the potentially devastating neurological 
effects, including GBS in adults and 
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